Candriam SCA’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.13M Hold
269,729
0.04% 312
2025
Q4
$9.36M Hold
269,729
0.05% 279
2025
Q3
$9.8M Buy
269,729
+134,950
+100% +$4.58M 0.05% 279
2025
Q2
$4.23M Sell
134,779
-6
-0% -$186 0.02% 380
2025
Q1
$4M Hold
134,785
0.03% 375
2024
Q4
$3.98M Sell
134,785
-5,221
-4% -$165K 0.02% 389
2024
Q3
$4.36M Sell
140,006
-173,417
-55% -$6.31M 0.03% 387
2024
Q2
$10.6M Buy
313,423
+124,417
+66% +$6.35M 0.06% 247
2024
Q1
$12.3M Buy
189,006
+45,000
+31% +$3.09M 0.08% 233
2023
Q4
$9.84M Sell
144,006
-149,005
-51% -$7.74M 0.07% 253
2023
Q3
$15.2M Sell
293,011
-57,003
-16% -$3.37M 0.11% 180
2023
Q2
$21M Buy
350,014
+32,254
+10% +$1.84M 0.15% 154
2023
Q1
$14.5M Buy
317,760
+198,685
+167% +$11.2M 0.1% 209
2022
Q4
$6.8M Sell
119,075
-247
-0.2% -$13.9K 0.05% 333
2022
Q3
$5.6M Buy
+119,322
New +$5.69M 0.04% 358

Other funds holding IMCR